Transaction · 0001676170-26-000007

Coloma Jason V

Coloma Jason V, CEO, reported an open-market or private sale at Maze Therapeutics, Inc. involving 4504.000000 shares for an estimated $117104.45. Reported holdings after the transaction were 376569.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCEO
MAZEMaze Therapeutics, Inc.
Filing timeMay 27
Trade dateMay 22, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$26.05
Pre-filing
1mo ago +1.7%1w ago -1.9%1d ago -1.2%
Returns since
7d -4.6%30d +9.1%90d +17.0%180d +17.0%1y +17.0%

MAZE price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
MAZE since 2026-05-27Filed 101 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001676170-26-000007
Common Stock
Transaction date
May 22, 2026
Filed May 27, 2026, 08:16 PM · 5d delay
Shares
4.50k sh
$2.60k per share
Estimated value
-$11.7M
Computed from shares × price
Holdings after
376k sh
Indirect · Coloma Family Trust

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
10b5-1 Detected
-10score
Filing-only score

-10

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Executive Officer

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

  2. F2

    The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.105 per share, inclusive. The reporting person undertak…

  3. F3

    These securities are directly held by the Coloma Family Trust (the "Family Trust"), for which the reporting person and his spouse serve as co-trustees.

  4. F4

    These securities are directly held by The Coloma 2021 Irrevocable Trust (the "Irrevocable Trust"), for which the reporting person and his spouse serve as co-trustees.

  5. F5

    The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.09 per share, inclusive.

Original filing · 0001676170-26-000007
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

MAZE